Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Rajesh Kumar's Stock Ratings
HSBC Analyst
Rajesh Kumar is an analyst at HSBC. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/18/2025
Overall Average Return
12.7%
Smart Score
Overall Average Return Percentile
67th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/28/2025 | LLY | Buy Now | Eli Lilly | $782.91 | -10.59% | Rajesh Kumar61% | $1150 → $700 | Downgrade | Buy → Reduce | Get Alert |
| 04/25/2025 | KDP | Buy Now | Keurig Dr Pepper | $33.21 | 26.47% | Rajesh Kumar61% | $36 → $42 | Upgrade | Hold → Buy | Get Alert |
| 04/25/2025 | IQV | Buy Now | IQVIA Hldgs | $154.61 | 3.49% | Rajesh Kumar61% | $260 → $160 | Downgrade | Buy → Hold | Get Alert |
| 06/05/2024 | ABBV | Buy Now | AbbVie | $185.00 | — | Rajesh Kumar61% | → $185 | Upgrade | Hold → Buy | Get Alert |
| 04/30/2024 | TMO | Buy Now | Thermo Fisher Scientific | $391.23 | 71.25% | Rajesh Kumar61% | $660 → $670 | Maintains | Buy | Get Alert |
| 04/17/2024 | TMO | Buy Now | Thermo Fisher Scientific | $391.23 | 68.7% | Rajesh Kumar61% | $630 → $660 | Maintains | Buy | Get Alert |
| 04/17/2024 | DHR | Buy Now | Danaher | $194.44 | 44% | Rajesh Kumar61% | $250 → $280 | Upgrade | Hold → Buy | Get Alert |
| 04/04/2024 | UNH | Buy Now | UnitedHealth Group | $306.29 | 50.18% | Rajesh Kumar61% | → $460 | Upgrade | Reduce → Hold | Get Alert |
| 12/18/2023 | DHR | Buy Now | Danaher | $194.44 | — | Rajesh Kumar61% | — | Initiates | → Hold | Get Alert |
| 12/18/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.06 | -23.8% | Rajesh Kumar61% | → $13 | Initiates | → Buy | Get Alert |
| 12/18/2023 | TMO | Buy Now | Thermo Fisher Scientific | $391.23 | 55.92% | Rajesh Kumar61% | → $610 | Initiates | → Buy | Get Alert |
| 12/18/2023 | ABBV | Buy Now | AbbVie | $185.00 | -15.68% | Rajesh Kumar61% | $167 → $156 | Downgrade | Buy → Hold | Get Alert |
| 12/18/2023 | UNH | Buy Now | UnitedHealth Group | $306.29 | 56.71% | Rajesh Kumar61% | $550 → $480 | Downgrade | Hold → Reduce | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.98 | 12.82% | Rajesh Kumar61% | $55 → $53 | Upgrade | Reduce → Hold | Get Alert |
| 07/14/2023 | MRNA | Buy Now | Moderna | $25.45 | 281.14% | Rajesh Kumar61% | → $97 | Initiates | → Reduce | Get Alert |
| 07/14/2023 | BNTX | Buy Now | BioNTech | $104.51 | 18.65% | Rajesh Kumar61% | → $124 | Initiates | → Buy | Get Alert |
| 07/14/2023 | PFE | Buy Now | Pfizer | $23.87 | 109.47% | Rajesh Kumar61% | → $50 | Initiates | → Buy | Get Alert |
| 07/14/2023 | MRK | Buy Now | Merck & Co | $78.70 | 56.29% | Rajesh Kumar61% | → $123 | Initiates | → Hold | Get Alert |
| 07/14/2023 | LLY | Buy Now | Eli Lilly | $782.91 | -28.47% | Rajesh Kumar61% | → $560 | Initiates | → Buy | Get Alert |
| 07/14/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.98 | 19.2% | Rajesh Kumar61% | → $56 | Initiates | → Reduce | Get Alert |
| 07/14/2023 | ABBV | Buy Now | AbbVie | $185.00 | -9.73% | Rajesh Kumar61% | → $167 | Initiates | → Buy | Get Alert |
